Medical Book

Search

Showing results for: Array

    Medical Book

    1.41

    1.41

    Persistent supraventricular rhythm / tachycardia (MC 8-4-1).

    Code 1.41 — persistent supraventricular rhythm / tachycardia (Novacode rhythm class 1, equivalent to Minnesota Code 8-4-1). Supraventricular tachycardia (SVT) is an abnormally fast heart rhythm arising from improper electrical activity in the upper part of the heart — the atria or the atrioventricular (AV) node. Code 1.41 describes a supraventricular rhythm with narrow QRS complexes that is present throughout the recording.

    ArrhythmiaSupraventricular tachycardiaNarrow QRS
    Heart rateusually 150–250 bpm
    QRS< 0.12 s (narrow)
    Minnesota Code8-4-1 persistent
    Rhythmregular

    Types of supraventricular tachycardia

    TypeMechanismTypical ECG
    AV nodal re-entrant tachycardia (AVNRT)Re-entry circuit within or near the AV node — the most common SVTRegular narrow QRS, P waves hidden in or just after QRS
    AV re-entrant tachycardia (AVRT)Circuit using an accessory pathway (e.g. WPW)Regular narrow QRS, retrograde P after QRS
    Focal atrial tachycardiaRapid firing from one atrial focusAbnormal P waves before each QRS
    Atrial flutter (regular conduction)Macro-re-entry in the right atrium"Saw-tooth" flutter waves, often 2:1 conduction ≈ 150 bpm
    Normal sinus rhythm compared with supraventricular tachycardia: narrow QRS complexes at a high rate without visible P waves Sinus rhythm P before every QRS PR 160 ms SVT P not visible, rate ≈ 180/min
    Figure 1. Left: sinus rhythm with a P wave before every QRS. Right: supraventricular tachycardia — narrow QRS complexes at a high rate, P waves hidden in the QRS or T wave.

    Symptoms and risks

    • Sudden onset and termination of palpitations, often felt in the neck
    • Dizziness, shortness of breath, chest discomfort, anxiety, need to urinate after the episode
    • Fainting is uncommon but possible at very high rates or with underlying heart disease
    • SVT is usually not life-threatening in a structurally normal heart, but persistent tachycardia lasting weeks can weaken the heart muscle (tachycardia-induced cardiomyopathy)

    Management

    Acute episodes are often stopped by vagal manoeuvres (for example the modified Valsalva manoeuvre); if unsuccessful, intravenous adenosine is used in hospital. Recurrent SVT can be prevented with medicines or, very effectively, cured by catheter ablation. Persistent SVT recorded on the ECG requires assessment by a cardiologist.

    Seek urgent care

    if a fast heartbeat is accompanied by chest pain, fainting, severe breathlessness, or does not stop within 15–20 minutes.

    References

    1. Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia. Circulation. 2016;133(14):e506–e574. doi:10.1161/CIR.0000000000000311
    2. Prineas RJ, Crow RS, Zhang ZM. The Minnesota Code Manual of Electrocardiographic Findings. 2nd ed. London: Springer; 2010. doi:10.1007/978-1-84882-778-3

    This article is for general information and does not replace a consultation with a doctor. ECG findings must be interpreted by a physician together with symptoms and other tests.

    Published on 14 May 2019